Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Palmieri%2C+Salvatore%22&type=Person&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22
/vufind/Search/Results?lookfor=%22Palmieri%2C+Salvatore%22&type=Person&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22
Search /vufind/Search2/Results?lookfor=%22Palmieri%2C+Salvatore%22&type=Person&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22
PubPharm (40)
1
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
enthalten in:
The New England journal of medicine
| 2024
von
Sonneveld, P.
|
Dimopoulos, M.
|
Boccadoro, M.
| +141
CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009
Wird geladen...
2
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma : a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials
enthalten in:
Haematologica
| 2024
von
Gentile, M.
|
Vigna, E.
|
Palmieri, S.
| +44
Wird geladen...
3
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders : A Multicenter Real-Life Experience
enthalten in:
Targeted oncology
| 2023
von
De Novellis, D.
|
Fontana, R.
|
Palmieri, S.
| +30
Wird geladen...
4
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience
enthalten in:
Targeted oncology
| 2023
von
De Novellis, D.
|
Fontana, R.
|
Palmieri, S.
| +30
Wird geladen...
5
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients : italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
enthalten in:
Hematological oncology
| 2022
von
Martino, E.
|
Conticello, C.
|
Zamagni, E.
| +30
Wird geladen...
6
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
enthalten in:
Hematological oncology
| 2022
von
Bruzzese, A.
|
Derudas, D.
|
Galli, M.
| +57
Wird geladen...
7
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Bertamini, L.
|
Oliva, S.
|
Rota-Scalabrini, D.
| +26
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3099-3102. - PMID 35759726
Wird geladen...
8
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients
enthalten in:
European journal of haematology
| 2022
von
Morabito, F.
|
Zamagni, E.
|
Conticello, C.
| +41
Wird geladen...
9
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy : Analysis of 919 Cases Outside Clinical Trials
enthalten in:
Frontiers in oncology
| 2022
von
Morabito, F.
|
Zamagni, E.
|
Conticello, C.
| +45
Wird geladen...
10
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients : A multicentric real-life experience
enthalten in:
Frontiers in oncology
| 2022
von
Iula, R.
|
De Novellis, D.
|
Trastulli, F.
| +21
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Medienart: E-Ressourcen
Medienart
40
Aufsätze
40
E-Artikel
E-Ressourcen
Zeitschriftentitel
10
Annals of hematology
6
Haematologica
5
Hematological oncology
3
European journal of haematology
2
Biology of blood and marrow transplantation : j...
2
European Journal of Haematology
2
Frontiers in oncology
2
Hematological Oncology
2
Journal of clinical oncology : official journal...
2
Targeted oncology
1
American journal of hematology
1
Cancer genetics and cytogenetics
1
Critical reviews in oncology/hematology
1
The New England journal of medicine
Alle anzeigen ...
weniger ...
Thema
23
Journal Article
10
Lenalidomide
9
Multicenter Study
8
7S5I7G3JQL
8
Dexamethasone
8
F0P408N6V4
5
elotuzumab
5
multiple myeloma
4
1351PE5UGS
4
Antibodies, Monoclonal
4
Letter
4
Multiple myeloma
3
04079A1RDZ
3
4Z8R6ORS6L
3
69G8BD63PP
3
Antibodies, Monoclonal, Humanized
3
Bortezomib
3
Busulfan
3
Carfilzomib
3
Klinische Studie
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
17
2020-
7
2010-2019
16
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
36
Englisch
Haven't found what you're looking for?
Wird geladen...